Skip to main content
. 2021 Nov 1;117(5):1018–1027. [Article in Portuguese] doi: 10.36660/abc.20190715

Table 1. Demographic and clinical characteristics of the study population.

Characteristics N = 130
n (%)
Age (years) (median) 83.0 (80.0-87.0)
Male sex 67 (51.5)
BMI (median) 25.3 (22.5-29.4)
Clinical presentation
Syncope 38 (29.2)
Angina pectoris 27 (20.8)
HF, NYHA functional class
II 6 (4.8)
III 70 (53.8)
IV 54 (41.5)
Systemic arterial hypertension 94 (72.3)
Diabetes mellitus 48 (36.9)
Coronary arterial disease 70 (53.8)
Previous AMI 15 (11.5)
Previous MRS 30 (23.1)
Previous PCI 42 (32.3)
Previous stroke 7 (5.4)
Peripheral vascular disease 31 (23.8)
COPD 12 (9.2)
Chronic kidney disease* 101 (77.7)
Pulmonary arterial hypertension 40 (30.8)
Previous pacemaker 25 (19.2)
STS mortality (%) 8.6 (4.8-19.3)
STS morbidity (%) 34.6 (24.8-63.1)
Anemia 83 (63.8)
Atrial fibrillation 17 (13.1)
LV dysfunction (LVEF < 50%) 33 (25.4)

BMI: body mass index; HF: heart failure; NYHA: New York Heart Association; AMI: acute myocardial infarction; MRS: myocardial revascularization surgery; PCI: percutaneous coronary intervention; COPD: chronic obstructive pulmonary disease; STS: Surgeons Thoracic Society; LV: left ventricle LVEF: LV ejection fraction.

*

Glomerular filtration rate estimated by the Cockcroft-Gault formula < 60 mL/min.